Polaris Market Research recently launched the latest update on U.S. Point of Care (PoC) Diagnostics Market Size, Share, Trends, & Industry Analysis Report By Product (Glucose Testing, Hb1Ac Testing, Coagulation), By Mode of Prescription, By End Use – Market Forecast, 2025-2034 that gives an extensive outlook of the market, analyzing facts, current growth factors, future trends, historical data, attentive opinions, and industry-validated data forecasts.
U.S. Point of Care (PoC) Diagnostics Market is currently valued at USD 9.69 billion in 2024 and is anticipated to generate an estimated revenue of USD 18.83 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.88% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034
𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
http://www.polarismarketresearch.com/industr…for-sample
The U.S. PoC diagnostics market is expanding rapidly due to increasing demand for quick, accurate, and decentralized testing solutions. Growth is driven by rising prevalence of chronic diseases, infectious disease outbreaks, and a shift toward preventive healthcare.
Technological advancements in biosensors, microfluidics, and handheld analyzers are improving diagnostic accuracy and speed. Retail clinics, pharmacies, and home-care settings are becoming major adoption channels.
PoC testing is increasingly integrated with digital health platforms, enabling real-time data sharing and remote decision making. Government initiatives supporting early diagnosis and patient-centric care also drive market penetration.
The rise of telehealth services enhances remote testing workflows. High R&D investment by diagnostic companies accelerates product innovation.
Reimbursement improvements and regulatory support are further enhancing adoption. Overall, the market is highly competitive with strong participation from global diagnostic leaders.
U.S. Point of Care (PoC) Diagnostics Market Key Growth Drivers
* Growing demand for rapid diagnostic testing in emergency care
* Rising prevalence of chronic and infectious diseases
* Increased adoption of portable diagnostic devices in home healthcare
* Advancements in molecular PoC testing technologies
* Favorable government initiatives for improving diagnostic accessibility
* Expansion of decentralized testing in clinics and pharmacies
* Growth of telehealth-integrated PoC solutions
Key Player Analysis:
The report provides a detailed analysis of the U.S. Point of Care (PoC) Diagnosticss Market key players encompassing their product and service market segmentation, revenue, share, product portfolios, capabilities, market positions, geographic footprints, and entry strategies.
The report helps readers comprehend the unique positions that these businesses hold in the developing worldwide market. Sales figures, gross margin analysis, profit margins, and price patterns concerning each firm have been inculcated in the report.
𝐌𝐚𝐣𝐨𝐫 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
* Abbott
* Agilent Technologies, Inc.
* BD
* BIOMÉRIEUX
* Danaher Corporation
* Hologic, Inc.
* Illimina, Inc.
* Quest Diagnostics Incorporated
* QuidelOrtho Corporation
* Thermo Fisher Scientific Inc
𝐕𝐢𝐬𝐢𝐭 𝐎𝐮𝐫 𝐖𝐞𝐛𝐬𝐢𝐭𝐞 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
http://www.polarismarketresearch.com/industr…ics-market
Key Findings from The Report:
* The report illustrates an analysis showing product/service consumption in a region along with elements influencing the U.S. Point of Care (PoC) Diagnosticss Market in each area.
* Report outlines the global potential and risks that vendors must deal with.
* The analysis identifies the regions and industries with the most potential for growth.
* A competitive market with notable firm rankings, the introduction of new products, corporate growth, and acquisitions is incorporated in the report.
* The research includes business overviews, corporate insights, product benchmarking, and SWOT analysis for each important market participant.
* The report takes into account current developments, motivating factors, obstacles, and geographical constraints that are present in developed regions.
Segmentation Overview:
U.S. Point of Care (PoC) Diagnostics Market segmentation analysis is done on the basis of types, applications, regions, and key players. The market’s key demographic, regional, and behavioral data are aimed at helping to determine the characteristics a firm should offer in order to meet the needs of the business.
Also, market maker information is used to categorize the study to better understand clients buying behavior and patterns for the consumer-based market. Our analysts ensure the report is segmented with accurate marketing & sales channels to recognize prospective industry size by revenue and volume.
U.S. Point of Care (PoC) Diagnostics Market, Product Outlook (Revenue – USD Billion, 2020-2034)
* Glucose Testing
* Hb1Ac Testing
* Coagulation
* Fertility
* Infectious Diseases
* Cardiac Markers
* Thyroid Stimulating Hormone
* Hematology
* Primary Care Systems
* Decentralized Clinical Chemistry
* Feces
* Lipid Testing
* Cancer Marker
* Blood Gas/Electrolytes
* Ambulatory Chemistry
* Drug Abuse Testing
* Urinalysis
U.S. Point of Care (PoC) Diagnostics Market, Mode of Prescription Outlook (Revenue – USD Billion, 2020-2034)
* OTC
* Prescription-based
U.S. Point of Care (PoC) Diagnostics Market, End Use Outlook (Revenue – USD Billion, 2020-2034)
* Clinics
* Hospitals
* Home
* Assisted Living Healthcare Facilities
* Laboratory
𝐀𝐬𝐤 𝐀𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐅𝐨𝐫 𝐘𝐨𝐮𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐒𝐚𝐦𝐩𝐥𝐞:
http://www.polarismarketresearch.com/industr…tomization
Key Questions Answered in Report
Q – What is the size of the market for a specific product or service, and what are the primary drivers and challenges?
Ans – Market valued at 9.69 billion in 2024, projected to reach 18.83 billion by 2034 at 6.88% CAGR; primary drivers are chronic disease prevalence, value-based care shift, government reimbursement policies, and technological advancements; challenges include supply chain disruptions.
Q – What are the top players in a specific industry or market, as well as their shares, competitive tactics, and strengths and weaknesses?
Ans – Major players include Abbott, Roche, Siemens, Danaher, Thermo Fisher Scientific, BD, Quest Diagnostics; competitive tactics focus on connectivity, multiplex testing, and hospital-at-home programs; strengths include innovation and market expansion strategies.
Q – What are the present patterns and future growth prospects for a specific sector or market, and what causes are driving these trends?
Ans – Present trends include decentralized testing, AI integration, wearable sensors, CRISPR-based molecular testing, and self-monitoring adoption; future growth driven by home healthcare expansion, connected devices, and electronic health record integration.
Q – What are the opportunities and challenges that businesses in a specific industry face?
Ans – Opportunities include OTC diagnostic growth, ambulatory chemistry expansion, telemedicine integration, and hospital-at-home programs; challenges include navigating regulatory requirements, supply chain issues, and reimbursement policy changes.
Q – What are the most recent industry developments that can be used to produce new revenue streams?
Ans – July 2023 Lumos Diagnostics received FDA clearance for FebriDx rapid PoC test for respiratory infection evaluation and December 2024 NIH allocated 4 million for HIV diagnostic monitoring platforms creating new revenue opportunities.
News From
Polaris Market Research &…
Category: Industry Reports & Market Analysis Profile: Polaris Market Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight and market intelligence to our customers across various industries. We at Polaris are obliged to serve our client base across the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, ch …
This email address is being protected from spambots. You need JavaScript enabled to view it.
